Michael King is CHIEF FINANCIAL OFFICER of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 5,000 shares of SABS, which is worth approximately $19,950. The most recent transaction as insider was on Nov 30, 2023, when has been sold 5,000 shares (Common Stock) at a price of $0.9 per share, resulting in proceeds of $4,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $19,950

Michael King Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2023
BUY
Open market or private purchase
$4,500 $0.9 p/Share
5,000 Added 50.0%
5,000 Common Stock
MK

Michael King

CHIEF FINANCIAL OFFICER
Sioux Falls, SD

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Track Activities on SABS